Open AccessThe level of S100b protein in blood serum of patients with hiv/tb co-infectoin as a neurospecific biomarker of neurotoxicity
Author(s) -
В.В. Маврутенков,
Natalia V. Zhukova,
L. O. Kravchuk
Publication year - 2015
Publication title -
medična ì klìnìčna himiâ
Language(s) - English
Resource type - Journals
eISSN - 2414-9934
pISSN - 2410-681X
DOI - 10.11603/mcch.2410-681x.2015.v17.i2.4864
Subject(s) - neurotoxicity , biomarker , context (archaeology) , human immunodeficiency virus (hiv) , medicine , immunology , central nervous system , pharmacology , toxicity , biology , biochemistry , paleontology
There was studied the influence of antiretroviral and antimycobacterial chemotherapy on releasing from the glia cell marker lesions – S100b protein in the context of possible iatrogenic. It was established that a slight increase in the concentration of S100b protein in blood serum of patients with co-infection of HIV /TB after starting HAART was not associated with the occurrence of symptoms of the central nervous system.